← Browse by Condition
Medical Condition

intracranial aneurysm

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for intracranial aneurysm sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — intracranial aneurysm Clinical Trials

How many clinical trials are currently recruiting for intracranial aneurysm?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for intracranial aneurysm, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intracranial aneurysm?
intracranial aneurysm research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intracranial aneurysm clinical trial?
Eligibility criteria for intracranial aneurysm trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Shanghai Wallaby Medical Technologies Co.,Inc. 1 trial
Zhujiang Hospital 1 trial
University Hospital, Ghent 1 trial
University Hospital, Geneva 1 trial

Recruiting Clinical Trials

NCT06158087
Recruiting

To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms

Enrollment
130 pts
Location
China
Sponsor
Shanghai Wallaby Medical Techn...
View Trial →
NCT06456814
Recruiting

Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China

Enrollment
30,000 pts
Location
China
Sponsor
Zhujiang Hospital
View Trial →
NCT06588543
Recruiting

Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping

Enrollment
500 pts
Location
Belgium
Sponsor
University Hospital, Ghent
View Trial →
NCT03245866
Recruiting

Swiss Study on Subarachnoid Hemorrhage

Enrollment
5,000 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology